Serotonin: Another player in the complex pathogenesis of no-reflow phenomenon

References (11)

1. Bolognese L, Carrabba N, Parodi G, Santoro GM, Buonamici P, Cerisano G, et al. Impact of microvascular dysfunction on left ventricular remodeling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction. Circulation 2004
2. doi:10.1161/01.CIR.0000118496.44135.A7 PMid:14967718 2. Niccoli G, Burzotta F, Galiuto L, Crea F. Myocardial no-reflow in humans. J Am Coll Cardiol 2009
3. doi:10.1016/j.jacc.2009.03.054 PMid:19608025 3. Topsakal R, Kaya MG, Karakaya E, Günebakmaz Ö, Doğan A, İnanç MT, et al. No-reflow phenomenon and serotonin levels in patients with acute ST-elevation myocardial infarction who underwent primary percutaneous intervention. Anadolu Kardiyol Derg 2010: 10
4. Kawai C. Pathogenesis of acute myocardial infarction. Novel regulatory systems of bioactive substances in the vessel wall. Circulation 1994
5. PMid:8044917 5. Piana RN, Paik GY, Moscucci M, Cohen DJ, Gibson CM, Kugelmass AD, et al. Incidence and treatment of 'no-reflow' after percutaneous coronary intervention. Circulation 1994
6. PMid:8205658 6. Morishima I, Sone T, Mokuno S, Taga S, Shimauchi A, Oki Y, et al. Clinical significance of no-reflow phenomenon observed on angiography after successful treatment of acute myocardial infarction with percutaneous transluminal coronary angioplasty. Am Heart J 1995
7. doi:10.1016/0002-8703(95)90434-4 7. Niccoli G, Lanza GA, Shaw S, Romagnoli E, Gioia D, Burzotta F, et al. Endothelin-1 and acute myocardial infarction: a no-reflow mediator after successful percutaneous myocardial revascularization. Eur Heart J 2006
8. doi:10.1093/eurheartj/ehl119 PMid:16829540 8. Niccoli G, Giubilato S, Russo E, Spaziani C, Leo A, Porto I, et al. Plasma levels of thromboxane A2 on admission are associated with no-reflow after primary percutaneous coronary intervention. Eur Heart J 2008
9. doi:10.1093/eurheartj/ehn325 PMid:18617477 9. Taylor AJ, Bobik A, Berndt MC, Ramsay D, Jennings G. Experimental rupture of atherosclerotic lesions increases distal vascular resistance: a limiting factor to the success of infarct angioplasty. Arterioscler Thromb Vasc Biol 2002
10. doi:10.1161/hq0102.101128 10. Vitola JV, Forman MB, Holsinger JP, Kawana M, Atkinson JB, Quertermous T, et al. Role of endothelin in a rabbit model of acute myocardial infarction: effects of receptor antagonists. J Cardiovasc Pharmacol 1996
11. doi:10.1097/0000534